"In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my objective insights on markets, sectors, and companies."
Looking for timely, proven, accountable sector ETF and sector mutual fund recommendations to invest now? Learn how AlphaProfit model portfolios leverage the power of sector investing to deliver strong returns. See: Performance of ETF Model Portfolios and Performance of Fidelity Mutual Funds Model Portfolios.
High-potential diversified portfolios can be constructed by dividing assets among a group of sector funds. This approach gives the investor flexibility to over-weight or under-weight certain sectors versus broadly diversified indexes. 'Sector funds are too risky.' 'I doubled my money with Fidelity Select Technology in 12 months!' 'Avoid sector funds.' If all of this sounds confusing, you are not alone.
If you are looking to earn great returns from the stock market sector mutual funds are right up your alley. Sophisticated investors recognize the potential sector mutual funds offer and know how to make such funds work for them. You can consistently beat the market by investing in the right sector mutual fund at the right time. In fact, you can make money even in bear markets.
Sector ETFs are among the most potent investment vehicles that allow individual investors to exploit advantages previously available only to large institutions. You can beat the market by investing in the right sector ETF at the right time. In fact, you can actually make money even when the overall market is tanking. However all too often, investors use sector ETFs inappropriately and get their fingers burnt.
The first half of 2009 has been tough on most momentum-based strategies. After declining 11.0% in the first quarter, the broad market turned around and staged a roaring rally. The S&P 500 is now up 15.7% for the second quarter. The snap in performance between the first and second quarters is even more striking at a sector level.… Read More »
Although the S&P 500 has advanced 32% since the March 9 market bottom, the rally has been quite selective from a sector perspective. Groups decimated during the recent bear market have rallied the most. Financial shares are up big after losing 81% from September 30, 2007. With investors demonstrating healthy risk appetite, defensive sectors have generally lagged. Utilities… Read More »
Mutual fund titans Vanguard and Fidelity are taking different approaches to compete against sector ETFs. The allure of low expense ratios, better transparency, and ready liquidity has made exchange-traded funds (ETFs) a popular investment vehicle. The robust returns earned off-late by energy and other commodity ETFs have resulted in money gravitating towards such ETFs. The Energy Select Sector… Read More »
This article originally appeared in The Motley Fool on December 14, 2005. Technology companies are generally underappreciated as energy conservation plays. By casting a wider net, investors can find appealing situations in the technology space that stand to prosper from the growing emphasis on energy conservation. Investors typically see oil-related stocks — such as Exxon Mobil (NYSE: XOM)… Read More »
Biotechnology, which has been on a roll, declined after the much-anticipated American Society of Clinical Oncologists meeting in early June in New Orleans, where cancer specialists deliberated on the merits of new treatments. The two extant ETFs which focus on this industry are iShares Nasdaq Biotechnology (AMEX:IBB) and Biotech HOLDRs (AMEX:BBH). Before deciding to dump or load up… Read More »
Investing in biotech stocks has never been for the faint-hearted as many biotech companies have high cash burn rates. The biotech industry however has a few things going for it. Read on to learn more about investment opportunities in this industry. Shares of biotechnology companies have declined, after the much anticipated American Society of Clinical Oncologists meeting in… Read More »
The favorable dynamics for the Biotechnology industry is attracting investor attention. On the heels of recent gains, there are reasons to be optimistic on continued out-performance. An efficient Food and Drug Administration, progress on extension of new products, trouble in ‘major pharma’ land and reasonable valuation create a favorable milieu for investing in the biotechnology sector. These conditions… Read More »
The Fidelity and ETF Core and Focus model portfolios have gained at annualized rates of 14.6% and 17.8%, respectively since 1994. The model portfolios will be repositioned with new mutual fund and ETF recommendations on Monday, September 30.
Learn more about AlphaProfit's Free and Premium Service investment newsletters.
THE GOOD NEWS JUST BEGINS!
DEC. 1993 to DEC. 2023| Fidelity Agg. Growth | 17.8% |
| Fidelity Growth | 14.6% |
| ETF Agg. Growth | 17.5% |
| ETF Growth | 14.3% |
| No-Fee Growth (inc. 2009) | 10.9% |
| S&P 500 | 10.1% |
DEC. 2013 to DEC. 2023| Win Rate | 91% |
| Avg. Holding Period | 2.6 months |
| Avg. Gain | 12.8% |
